/Lilly(Eli)%20%26%20Co%20logo%20on%20building-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Indianapolis, Indiana-based Eli Lilly and Company (LLY) is a pharmaceutical company that discovers, develops, and markets human pharmaceuticals. Valued at a market cap of $735.9 billion, the company is known for its groundbreaking treatments in areas such as diabetes, cancer, neuroscience, and immunology. It is expected to announce its fiscal Q2 earnings for 2025 before the market opens on Thursday, Aug. 7.
Ahead of this event, analysts expect this pharmaceuticals giant to report a profit of $5.55 per share, up 41.6% from $3.92 per share in the year-ago quarter. The company has topped Wall Street’s earnings estimates in two of the last four quarters, while missing on two other occasions. In Q1, LLY’s EPS of $3.34 fell short of the forecasted figure by 5.1%.
